Population Pharmacokinetics and Pharmacodynamics of Rivaroxaban — an Oral, Direct Factor Xa Inhibitor — in Patients Undergoing Major Orthopaedic Surgery

Overview of attention for article published in Clinical Pharmacokinetics, September 2012

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

patent: 8 patents

Citations

dimensions_citation: 223 Dimensions

Readers on

mendeley: 131 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 8 patents that reference this research output.

Pharmaceutical composition

Grant US-9707296-B2

United States of America

Method for producing optically active diamine derivative

Grant US-9175012-B2

United States of America

Process for preparation of optically active diamine derivative salt

Grant US-8901345-B2

United States of America

Crystal of diamine derivative and method of producing same

Grant US-8541443-B2

United States of America

Pharmaceutical composition having improved solubility

Grant US-8449896-B2

United States of America

Method for producing diamine derivative

Grant US-8404847-B2

United States of America

Activated blood coagulation factor inhibitor

Grant US-8394821-B2

United States of America

Process for producing diamine derivative

Grant US-8357808-B2

United States of America